Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium trial in ALS
NL-OMON31977Not yet recruiting
- Sponsor
- Prof. dr. L.H. van den Berg, neurologist Dep. neurology, UMC-Utrecht Heidelberglaan 100/HP G03.228 3584CX Utrecht Tel: +31-88-7557939 Fax: +31-30-2542100 Email: [email protected]
- Start
- Oct 2008
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of lithium carbonate in amyotrophic lateral sclerosis (ALS) (2 arms), sponsored by Prof. dr. L.H. van den Berg, neurologist Dep. neurology, UMC-Utrecht Heidelberglaan 100/HP G03.228 3584CX Utrecht Tel: +31-88-7557939 Fax: +31-30-2542100 Email: [email protected]. Primary endpoint: Survival. Planned start Oct 2008; status: not yet recruiting.
02
Drugs
lithium carbonate
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NL-OMON31977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31977.